High aromatase activity in hypogonadal men is associated with higher spine bone mineral density, increased truncal fat and reduced lean mass
Authors:
- Lina E AguirreLALina E Aguirre
- Georgia ColleluoriGCGeorgia Colleluori
- Kenneth E FowlerKFKenneth E Fowler
- Irum Zeb JanIJIrum Zeb Jan
- Clifford QuallsCQClifford Qualls
- David RobbinsDRDavid Robbins
- Dennis T VillarealDVDennis T Villareal
- Reina Armamento-VillarealRAReina Armamento-Villareal
- 1 August 2015
- journal article
- Published by Oxford University Press (OUP) in European Journal of Endocrinology
- Vol. 173 (2) , 167-174
Abstract
Objective: Because the aromatase enzyme catalyzes the conversion of testosterone to estradiol (E2), the activity of this enzyme could be important in the musculoskeletal health of men with low testosterone. The objective of the present study is to determine the influence of aromatase activity on the bone mineral density (BMD) and body composition of patients with hypogonadism.Design: Cross-sectional study.Methods: The baseline data of 90 patients between 40 and 74 years old who participated in a genetic study of response to testosterone therapy in men with low testosterone (i.e., 2was measured by ultrasensitive enzyme immunoassay, and sex hormone-binding globulin was measured by enzyme immunoassay.Results: Men in the highest tertile of E2to testosterone ratio (E2:T) had the highest spine BMD (P≤0.037), highest truncal fat (P=0.046), and lowest truncal lean body mass (P=0.045). A similar pattern was observed in the upper extremities; that is, fat mass significantly increased (P=0.047), whereas lean mass significantly decreased (P=0.034) with increasing E2:T tertiles.Conclusion: The present findings suggest that in men with hypogonadism, aromatase activity could be an important determinant of musculoskeletal health. Men with high aromatase activity are able to maintain a higher BMD despite low circulating testosterone, but they have lower lean and higher truncal fat mass as compared to those with lower aromatase activity.Keywords
This publication has 44 references indexed in Scilit:
- Gonadal Steroids and Body Composition, Strength, and Sexual Function in MenNew England Journal of Medicine, 2013
- Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European menOsteoporosis International, 2010
- The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: Is a revision needed?Journal of Bone and Mineral Research, 2010
- Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2010
- The benefits and risks of testosterone replacement therapy: a reviewTherapeutics and Clinical Risk Management, 2009
- Genetic Variations in Sex Steroid-Related Genes as Predictors of Serum Estrogen Levels in MenThe Journal of Clinical Endocrinology & Metabolism, 2009
- Levels of Sex Steroid and Cardiovascular Disease Measures in Premenopausal and Hormone-Treated Women at MidlifeJAMA Internal Medicine, 2008
- A novel mutation in the human aromatase gene: Insights on the relationship among serum estradiol, longitudinal growth and bone mineral density in an adult man under estrogen replacement treatmentBone, 2008
- Relationship of Volumetric BMD and Structural Parameters at Different Skeletal Sites to Sex Steroid Levels in MenJournal of Bone and Mineral Research, 2005
- Effect of CYP1A1 Gene Polymorphisms on Estrogen Metabolism and Bone DensityJournal of Bone and Mineral Research, 2004